KAITLYN PARKER: Open Payments
NPI 1659982262 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 41 payments from 12 companies in 2025. Trend: 2023 $1,934 · 2024 $1,467 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $433 |
| LEO Pharma Inc. | 3 | $163 |
| GENZYME CORPORATION | 3 | $118 |
| Janssen Biotech, Inc. | 2 | $116 |
| Lilly USA, LLC | 1 | $91 |
| Amgen Inc. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| UCB, Inc. | 2 | $38 |
| ConvaTec Inc. | 1 | $21 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, ANZUPGO, TREMFYA, EBGLYSS, OTEZLA, BOTOX.
Industry payments across AL — which companies pay providers there.
